Approval provided for Angelini’s cenobamate
Treatment will now be used across Ireland among adults with focal onset seizures with epilepsy
Read More
Tag: cenobamate
EC approval for Ontozry
The drug offers new hope for epilepsy patients with focal-onset seizures
Read More
EMA accepts Arvelle’s cenobamate MAA
There are about six million people in Europe with epilepsy, and approximately 40% of adults with focal-onset seizures continue to experience seizures.
Read More
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
